XSHE
002524
Market cap261mUSD
Jul 10, Last price
3.78CNY
1D
9.88%
1Q
-9.79%
Jan 2017
-64.47%
IPO
-55.26%
Name
Guangzheng Eye Hospital Group Co Ltd
Chart & Performance
P/E
—
P/S
2.20
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.05%
Rev. gr., 5y
-3.26%
Revenues
885m
-0.86%
Net income
-19m
L-88.84%
CFO
125m
+80.57%
Dividend
May 28, 20130.025 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guangzheng Eye Hospital Group Co., Ltd. provides various ophthalmic medical services in China. It operates through Steel Structure Segment; Energy Segment; and Medical and Health segment. The steel structure segment engaged in steel structure processing and sales and installation business. The energy segment involved in gas station leasing, oil and natural gas sales, and home installation business. The medical and health segment provides ophthalmic medical services. it offers diagnosis and treatment of various eye diseases; medical optometry services; invests in, operates, and manages eye hospitals; and provides related services. In addition, it engages in leasing of houses; and property and consulting services. The company formerly known as Guangzheng Group Co., Ltd. Guangzheng Eye Hospital Group Co., Ltd. was founded in 2001 and is headquartered in Xinjiang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||